DeepMed Research

Jonsson Comprehensive Cancer Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: Subsidiary

Employees: -

Market Cap: -

Website: http://www.cancer.ucla.edu

Clinical Trials

Alemtuzumab in Treating Patients With Waldenstrom's Macroglobulinemia

Phase 2

Withdrawn

Conditions: Lymphoma

First Posted Date: 2004-04-08

Last Posted Date: 2013-01-08

Lead Sponsor: Jonsson Comprehensive Cancer Center

Registration Number: NCT00081068

Locations: 🇺🇸
Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute, Boston, Massachusetts, United States
🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
🇺🇸
Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States

and more 12 locations

SU006668 in Treating Patients With Advanced Solid Tumors

Phase 1

Conditions: Breast Cancer
Colorectal Cancer
Gastric Cancer
Kidney Cancer
Lung Cancer
Multiple Myeloma and Plasma Cell Neoplasm
Pancreatic Cancer
Prostate Cancer

First Posted Date: 2004-04-06

Last Posted Date: 2013-12-19

Lead Sponsor: Jonsson Comprehensive Cancer Center

Registration Number: NCT00024063

Epoetin Alfa in Treating Chemotherapy-Related Anemia in Women With Stage I, Stage II, or Stage III Breast Cancer

Phase 4

Completed

Conditions: Anemia
Breast Cancer
Fatigue

First Posted Date: 2004-04-05

Last Posted Date: 2013-07-18

Lead Sponsor: Jonsson Comprehensive Cancer Center

Registration Number: NCT00022386

Carbendazim in Treating Patients With Advanced Solid Tumors or Lymphoma

Phase 1

Conditions: Lymphoma
Unspecified Adult Solid Tumor, Protocol Specific

First Posted Date: 2004-04-05

Last Posted Date: 2013-09-20

Lead Sponsor: Jonsson Comprehensive Cancer Center

Registration Number: NCT00023816

CCI-779 in Treating Patients With Prostate Cancer

Phase 2

Completed

Conditions: Prostate Cancer

First Posted Date: 2004-03-26

Last Posted Date: 2013-06-24

Lead Sponsor: Jonsson Comprehensive Cancer Center

Registration Number: NCT00012142

Locations: 🇺🇸
Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, United States

Monoclonal Antibody in Treating Patients With Acute Myelogenous Leukemia

Phase 2

Conditions: Leukemia

First Posted Date: 2004-03-25

Last Posted Date: 2013-12-19

Lead Sponsor: Jonsson Comprehensive Cancer Center

Registration Number: NCT00006084

Locations: 🇺🇸
Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, United States

Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy

Phase 1

Conditions: Prostate Cancer

First Posted Date: 2004-03-24

Last Posted Date: 2013-08-07

Lead Sponsor: Jonsson Comprehensive Cancer Center

Registration Number: NCT00005992

Locations: 🇺🇸
University of Texas - MD Anderson Cancer Center, Houston, Texas, United States
🇺🇸
Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, United States

Levofloxacin Compared With Cefepime in Treating Cancer Patients With Fever and Neutropenia

Phase 3

Conditions: Fever, Sweats, and Hot Flashes
Infection
Leukemia
Lymphoma
Neutropenia
Unspecified Adult Solid Tumor, Protocol Specific

First Posted Date: 2004-03-17

Last Posted Date: 2013-12-19

Lead Sponsor: Jonsson Comprehensive Cancer Center

Registration Number: NCT00020865

Locations: 🇺🇸
Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, United States

Cetuximab Plus Cisplatin in Treating Patients With Metastatic or Recurrent Cancer of the Head and Neck That Has Not Responded to Cisplatin Chemotherapy

Phase 2

Completed

Conditions: Head and Neck Cancer

First Posted Date: 2004-03-16

Last Posted Date: 2009-03-09

Lead Sponsor: Jonsson Comprehensive Cancer Center

Registration Number: NCT00004865

Locations: 🇺🇸
Kimball Medical Center, Lakewood, New Jersey, United States
🇺🇸
Monmouth Medical Center, Long Branch, New Jersey, United States
🇺🇸
Cooper Cancer Institute, Camden, New Jersey, United States

Voriconazole Compared With Itraconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Not Applicable

Completed

Conditions: Cancer

First Posted Date: 2004-03-10

Last Posted Date: 2020-08-03

Lead Sponsor: Jonsson Comprehensive Cancer Center

Registration Number: NCT00079222

Locations: 🇺🇸
Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy